The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy (Q43039715)
Jump to navigation
Jump to search
scientific article published in September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy |
scientific article published in September 2002 |
Statements
1 reference
The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy (English)
1 reference
Robert Jordan
1 reference
Serguey Ouzounov
1 reference
Anand Mehta
1 reference
Raymond A Dwek
1 reference
Timothy M Block
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference